3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lymphoma
32
Precursor Cell Lymphoblastic Leukemia-Lymphoma
27
Leukemia
22
Lymphoma, Non-Hodgkin
18
Hodgkin Disease
11
Leukemia, Myeloid, Acute
10
Myelodysplastic Syndromes
9
Leukemia, Lymphocytic, Chronic, B-Cell
9
Burkitt Lymphoma
8
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
7
Neoplasms
6
Lymphoma, Large B-Cell, Diffuse
6
Lymphoma, Mantle-Cell
5
Lymphoma, Follicular
5
Hematologic Neoplasms
5
Recurrence
4
Myeloproliferative Disorders
4
Multiple Myeloma
4
Leukemia, Biphenotypic, Acute
4
Leukemia, B-Cell
4
Hematologic Diseases
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Leukemia, Lymphoid
3
Waldenstrom Macroglobulinemia
2
Primary Myelofibrosis
2
Preleukemia
2
Precancerous Conditions
2
Neoplasms by Histologic Type
2
Lymphoproliferative Disorders
2
Lymphoma, Large-Cell, Immunoblastic
2
Interventions
fludarabine phosphate
2
Cyclophosphamide
2
AP 1903 reagent
2
fludarabine
1
Whole-Body Irradiation
1
Peripheral Blood Stem Cell Transplantation
1
Mesna
1
Busulfan
1
Alemtuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Thalassemia
×
Mesna
×
Lymphoid
×
Clear all
NCT00578292
2020-05-01
THALLO
Baylor College of Medicine
Phase NA
Terminated
10 enrolled
15 charts